# Meridian Holdings Inc.: financial statements, quarterly

MRDN · Nasdaq · CIK 1437925 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mrdn.md) · [Financials](/companies/mrdn/financials.md) · [Filings](/companies/mrdn/filings.md) · [Insiders](/companies/mrdn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mrdn/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-12-31) | Q1 FY2024 (2024-01-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [25.3 d](/filings/0001477932-25-001897.md) | [11.8](/filings/0001477932-24-001197.md) | [24.9](/filings/0001477932-25-003431.md) | [39.4](/filings/0001477932-25-005487.md) | [41.0](/filings/0001477932-25-007805.md) | [45.9 d](/filings/0001477932-26-001750.md) | [42.7](/filings/0001477932-26-002588.md) | [43.2](/filings/0001477932-26-004577.md) | [47.3](/filings/0001477932-25-007805.md) | [49.6 d](/filings/0001477932-26-001750.md) | [50.1](/filings/0001477932-26-002588.md) | [50.2](/filings/0001477932-26-004577.md) |
| Cost of revenue | $m | [6.8 d](/filings/0001477932-25-001897.md) | [8.5](/filings/0001477932-24-001197.md) | [7.2](/filings/0001477932-25-003431.md) | [17.7](/filings/0001477932-25-005487.md) | [18.6](/filings/0001477932-25-007805.md) | [19.1 d](/filings/0001477932-26-001750.md) | [18.5](/filings/0001477932-26-002588.md) | [18.9](/filings/0001477932-26-004577.md) | [20.9](/filings/0001477932-25-007805.md) | [21.1 d](/filings/0001477932-26-001750.md) | [22.0](/filings/0001477932-26-002588.md) | [23.3](/filings/0001477932-26-004577.md) |
| Gross profit | $m | [18.5 d](/filings/0001477932-25-001897.md) | [3.4](/filings/0001477932-24-001197.md) | [17.7](/filings/0001477932-25-003431.md) | [21.7](/filings/0001477932-25-005487.md) | [22.4](/filings/0001477932-25-007805.md) | [26.8 d](/filings/0001477932-26-001750.md) | [24.2](/filings/0001477932-26-002588.md) | [24.4](/filings/0001477932-26-004577.md) | [26.4](/filings/0001477932-25-007805.md) | [28.5 d](/filings/0001477932-26-001750.md) | [28.1](/filings/0001477932-26-002588.md) | [26.9](/filings/0001477932-26-004577.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001477932-26-002588.md) | [1.1 d](/filings/0001477932-26-004577.md) | not reported | not reported | [0.2](/filings/0001477932-26-002588.md) | [1.3 d](/filings/0001477932-26-004577.md) |
| Selling, general and administrative | $m | [16.7 d](/filings/0001477932-25-001897.md) | not reported | [14.0](/filings/0001477932-25-003431.md) | [21.6](/filings/0001477932-25-005487.md) | [23.4](/filings/0001477932-25-007805.md) | [26.9 d](/filings/0001477932-26-001750.md) | [24.3](/filings/0001477932-26-002588.md) | [26.7](/filings/0001477932-26-004577.md) | [26.8](/filings/0001477932-25-007805.md) | [122 d](/filings/0001477932-26-001750.md) | [25.0](/filings/0001477932-26-002588.md) | [24.4](/filings/0001477932-26-004577.md) |
| Operating income | $m | [1.8 d](/filings/0001477932-25-001897.md) | [0.3](/filings/0001477932-24-001197.md) | [3.7](/filings/0001477932-25-003431.md) | [0.1](/filings/0001477932-25-005487.md) | [(1.0)](/filings/0001477932-25-007805.md) | [(0.1) d](/filings/0001477932-26-001750.md) | [(0.1)](/filings/0001477932-26-002588.md) | [(2.3)](/filings/0001477932-26-004577.md) | [(0.4)](/filings/0001477932-25-007805.md) | [(93.4) d](/filings/0001477932-26-001750.md) | [3.2](/filings/0001477932-26-002588.md) | [2.4](/filings/0001477932-26-004577.md) |
| Interest expense | $m | [0.0 d](/filings/0001477932-25-001897.md) | [0.0](/filings/0001477932-24-001197.md) | [0.0](/filings/0001477932-25-003431.md) | [0.0](/filings/0001477932-25-005487.md) | [0.8](/filings/0001477932-25-007805.md) | [2.7 d](/filings/0001477932-26-001750.md) | [1.5](/filings/0001477932-26-002588.md) | [1.5](/filings/0001477932-26-004577.md) | [0.5](/filings/0001477932-25-007805.md) | [1.1 d](/filings/0001477932-26-001750.md) | [0.4](/filings/0001477932-26-002588.md) | [0.3](/filings/0001477932-26-004577.md) |
| Income tax | $m | [0.4 d](/filings/0001477932-25-001897.md) | [0.3](/filings/0001477932-24-001197.md) | [0.3](/filings/0001477932-25-003431.md) | [0.5](/filings/0001477932-25-005487.md) | [1.9](/filings/0001477932-25-007805.md) | [(0.1) d](/filings/0001477932-26-001750.md) | [(0.3)](/filings/0001477932-26-002588.md) | [0.5](/filings/0001477932-26-004577.md) | [0.2](/filings/0001477932-25-007805.md) | [(5.6) d](/filings/0001477932-26-001750.md) | [0.7](/filings/0001477932-26-002588.md) | [0.6](/filings/0001477932-26-004577.md) |
| Net income | $m | [2.0 d](/filings/0001477932-25-001897.md) | [0.1](/filings/0001477932-24-001197.md) | [4.0](/filings/0001477932-25-003431.md) | [0.1](/filings/0001477932-25-005487.md) | [(3.4)](/filings/0001477932-25-007805.md) | [(2.1) d](/filings/0001477932-26-001750.md) | [(0.3)](/filings/0001477932-26-002588.md) | [(3.7)](/filings/0001477932-26-004577.md) | [0.6](/filings/0001477932-25-007805.md) | [(88.7) d](/filings/0001477932-26-001750.md) | [2.2](/filings/0001477932-26-002588.md) | [2.0](/filings/0001477932-26-004577.md) |
| Diluted EPS | $ per share | not reported | [0.00](/filings/0001477932-24-001197.md) | [0.05](/filings/0001477932-25-003431.md) | [0.00](/filings/0001477932-25-005487.md) | [(0.03)](/filings/0001477932-25-007805.md) | not reported | [(0.02)](/filings/0001477932-26-002588.md) | [(0.31)](/filings/0001477932-26-004577.md) | [0.00](/filings/0001477932-25-007805.md) | not reported | [0.18](/filings/0001477932-26-002588.md) | [0.17](/filings/0001477932-26-004577.md) |
| Basic EPS | $ per share | not reported | [0.00](/filings/0001477932-24-001197.md) | [0.05](/filings/0001477932-25-003431.md) | [0.00](/filings/0001477932-25-005487.md) | [(0.03)](/filings/0001477932-25-007805.md) | not reported | [(0.02)](/filings/0001477932-26-002588.md) | [(0.31)](/filings/0001477932-26-004577.md) | [0.00](/filings/0001477932-25-007805.md) | not reported | [0.18](/filings/0001477932-26-002588.md) | [0.17](/filings/0001477932-26-004577.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | Q1 FY2024 (2024-01-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [12.0](/filings/0001477932-25-005487.md) | not reported | not reported | not reported | not reported |
| Current assets | $m | [26.9](/filings/0001477932-25-001897.md) | [24.2](/filings/0001477932-24-001197.md) | not reported | [48.6](/filings/0001477932-24-004695.md) | [56.7](/filings/0001477932-24-007000.md) | [45.1](/filings/0001477932-26-001750.md) | [45.9](/filings/0001477932-25-003431.md) | [39.0](/filings/0001477932-25-005487.md) | [39.1](/filings/0001477932-25-007805.md) | [35.4](/filings/0001477932-26-004577.md) | [30.5](/filings/0001477932-26-002588.md) | [35.2](/filings/0001477932-26-004577.md) |
| Total assets | $m | [79.9](/filings/0001477932-25-001897.md) | [37.1](/filings/0001477932-24-001197.md) | not reported | [192](/filings/0001477932-24-004695.md) | [213](/filings/0001477932-24-007000.md) | [214](/filings/0001477932-26-001750.md) | [214](/filings/0001477932-25-003431.md) | [210](/filings/0001477932-25-005487.md) | [210](/filings/0001477932-25-007805.md) | [118](/filings/0001477932-26-004577.md) | [112](/filings/0001477932-26-002588.md) | [115](/filings/0001477932-26-004577.md) |
| Current liabilities | $m | [17.6](/filings/0001477932-25-001897.md) | [4.7](/filings/0001477932-24-001197.md) | not reported | [51.3](/filings/0001477932-24-004695.md) | [69.4](/filings/0001477932-24-007000.md) | [63.6](/filings/0001477932-26-001750.md) | [62.0](/filings/0001477932-25-003431.md) | [63.6](/filings/0001477932-25-005487.md) | [64.4](/filings/0001477932-25-007805.md) | [59.6](/filings/0001477932-26-004577.md) | [53.3](/filings/0001477932-26-002588.md) | [60.1](/filings/0001477932-26-004577.md) |
| Total liabilities | $m | [19.9](/filings/0001477932-25-001897.md) | [5.0](/filings/0001477932-24-001197.md) | not reported | [101](/filings/0001477932-24-004695.md) | [115](/filings/0001477932-24-007000.md) | [105](/filings/0001477932-26-001750.md) | [102](/filings/0001477932-25-003431.md) | [85.3](/filings/0001477932-25-005487.md) | [82.7](/filings/0001477932-25-007805.md) | [69.7](/filings/0001477932-26-004577.md) | [61.4](/filings/0001477932-26-002588.md) | [63.9](/filings/0001477932-26-004577.md) |
| Long-term debt | $m | [0.0](/filings/0001477932-25-001897.md) | not reported | not reported | [19.4](/filings/0001477932-24-004695.md) | [16.2](/filings/0001477932-24-007000.md) | [14.4](/filings/0001477932-26-001750.md) | [13.5](/filings/0001477932-25-003431.md) | [11.3](/filings/0001477932-25-005487.md) | [8.7](/filings/0001477932-25-007805.md) | [6.6](/filings/0001477932-26-004577.md) | [4.9](/filings/0001477932-26-002588.md) | [0.2](/filings/0001477932-26-004577.md) |
| Current portion of debt | $m | [0.0](/filings/0001477932-25-001897.md) | not reported | not reported | [6.0](/filings/0001477932-24-004695.md) | [17.5](/filings/0001477932-24-007000.md) | [16.8](/filings/0001477932-26-001750.md) | [15.1](/filings/0001477932-25-003431.md) | [11.2](/filings/0001477932-25-005487.md) | [10.9](/filings/0001477932-25-007805.md) | [10.6](/filings/0001477932-26-004577.md) | [8.0](/filings/0001477932-26-002588.md) | [10.0](/filings/0001477932-26-004577.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [59.0](/filings/0001477932-25-001897.md) | [32.1](/filings/0001477932-24-001197.md) | [61.4](/filings/0001477932-25-005487.md) | [90.4](/filings/0001477932-25-007805.md) | [94.3](/filings/0001477932-24-007000.md) | [105](/filings/0001477932-26-001750.md) | [109](/filings/0001477932-25-003431.md) | [121](/filings/0001477932-25-005487.md) | [124](/filings/0001477932-25-007805.md) | [46.5](/filings/0001477932-26-004577.md) | [48.7](/filings/0001477932-26-002588.md) | [49.7](/filings/0001477932-26-004577.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | period not labelled (2023-12-31) | Q1 FY2024 (2024-01-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [8.4 d](/filings/0001477932-25-001897.md) | [0.0](/filings/0001477932-24-001197.md) | [4.5](/filings/0001477932-25-003431.md) | [(1.9) d](/filings/0001477932-25-005487.md) | [4.8 d](/filings/0001477932-25-007805.md) | [16.6 d](/filings/0001477932-26-001750.md) | [7.7](/filings/0001477932-26-002588.md) | [2.4 d](/filings/0001477932-26-004577.md) | [7.0 d](/filings/0001477932-25-007805.md) | [8.2 d](/filings/0001477932-26-001750.md) | [5.2](/filings/0001477932-26-002588.md) | [7.8 d](/filings/0001477932-26-004577.md) |
| Capital expenditure | $m | [2.3 d](/filings/0001477932-25-001897.md) | [0.0](/filings/0001477932-24-001197.md) | [0.9](/filings/0001477932-25-003431.md) | [0.6 d](/filings/0001477932-25-005487.md) | [2.5 d](/filings/0001477932-25-007805.md) | [3.2 d](/filings/0001477932-26-001750.md) | [1.1](/filings/0001477932-25-003431.md) | [2.5 d](/filings/0001477932-26-004577.md) | [0.8 d](/filings/0001477932-25-007805.md) | [1.8 d](/filings/0001477932-26-001750.md) | not reported | not reported |
| Dividends paid | $m | [0.4 d](/filings/0001477932-25-001897.md) | not reported | [0.8](/filings/0001477932-25-003431.md) | [0.0 d](/filings/0001477932-24-004695.md) | [0.0 d](/filings/0001477932-24-007000.md) | [0.0 d](/filings/0001477932-26-001750.md) | [0.0](/filings/0001477932-25-003431.md) | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001477932-25-007805.md) | [(105) d](/filings/0001477932-26-001750.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2023-06-30) | Q3 FY2023 (2023-07-31) | period not labelled (2023-09-30) | Q1 FY2024 (2024-01-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [83.5](/filings/0001477932-24-004695.md) | [36.1](/filings/0001477932-23-006683.md) | [83.5](/filings/0001477932-24-007000.md) | [38.8](/filings/0001477932-24-001197.md) | [83.5](/filings/0001477932-25-003431.md) | [128](/filings/0001477932-25-005487.md) | [122](/filings/0001477932-25-007805.md) | [11.0](/filings/0001477932-26-002588.md) | [11.5](/filings/0001477932-26-004577.md) | [143](/filings/0001477932-25-007805.md) | [12.8](/filings/0001477932-26-002588.md) | [12.8](/filings/0001477932-26-004577.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,669,479 at 2026-07-29, from the cover of the [10-Q filed 2026-07-29](/filings/0001477932-26-004577.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.